Beijing Unwound a Closed $2 Billion Deal. Closing Certainty Is Now a Political Variable.
Beijing's order to unwind Meta's closed Manus deal shows closing certainty now depends on the founders' home state, so cross-border sellers must price political reversal into signing.
Read More
Megafunds Took 73% of the Money. The Single-Digit-Billion Exit Is Now an Orphan.
Five firms took 73% of new US venture capital in Q1 2026. Allegory Capital's portfolio model shows why the orphaned single-digit-billion exit rewards investors who diversify across vehicles.
Read More
Users Buy the Product. Organisations Buy the Company.
Product-market fit proves users want the product; procurement fit proves the organisation can buy the company, and in regulated Europe that second fit is an investable asset.
Read More
Why Regulated-Industry Startups Are Capturing Disproportionate Series B Capital in Europe: What the Investment Thesis Actually Requires
TLDR: Regulated-industry startups in healthtech, insurtech, legaltech, and compliance-tech are capturing an...
Read More
ONWARD Medical Skipped Swiss Funds, Found European Specialists, and Reached a Euronext IPO
An investor read: a 'no' from the wrong-mandate fund is information about fit, not a verdict on the company.
Read More
Investors Decide on Founders in the First Ninety Seconds, Not the Pitch Deck
From the other side of the table: what an early-stage investor is actually underwriting is the founder, not the slides.
Read More
A 25% Stake Can Be Worth Zero: How Liquidation Waterfalls Really Pay Out
Liquidation waterfalls pay senior preferred shareholders first, so a 25 per cent ownership stake can return nothing — ownership percentage anchors expectations that seniority quietly overrides at exit.
Read More
Where April 2025 Digital Health Capital Actually Went
April 2025's biggest digital-health cheques went to diagnostics, metabolic hardware, care-operations software, and fertility infrastructure. Where value compounds next.
Read More
AI Screens Deals 537× Faster, but Venture Fees Keep Climbing
An AI agent now screens early-stage deals 537 times faster than a human analyst, yet venture management fees keep rising — because the fee was never only the price of screening labour.
Read More
Venture Funds Stopped Returning Cash. LPs Rewrote the Scorecard Around DPI.
Distributions to paid-in has overtaken paper marks as the number limited partners trust, and the 2017 vintage shows even strong funds returning roughly a quarter of committed capital eight years in.
Read More